AG
DTIL icon

Aperio Group’s Precision BioSciences DTIL Stock Holding History

Aperio Group’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$203K Buy
813
+243
+43% +$59.6K ﹤0.01% 2304
2020
Q3 		$105K Buy
570
+124
+28% +$24.7K ﹤0.01% 2314
2020
Q2 		$112K Sell
446
-14
-3% -$3.07K ﹤0.01% 2261
2020
Q1 		$83K Buy
+460
New +$120K ﹤0.01% 2234

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
WHAM
Windmill Hill Asset Management Waddesdon, United Kingdom $321M AUM 25.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aperio Group's DTIL Position: Q4 2020 in Review

Aperio Group increased its Precision BioSciences (DTIL) stake by 43% in Q4 2020, buying an estimated $59.6K and bringing the position to 813 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #2304.

Aperio Group first reported a position in DTIL in Q1 2020 and has held it in 4 quarters since. 118 funds tracked by Wall St. Rank hold DTIL as of Q4 2020.

  • Aperio Group held 813 shares of Precision BioSciences worth $203K as of Q4 2020.
  • Aperio Group bought 243 Precision BioSciences shares in Q4 2020, an estimated $59.6K.
  • Precision BioSciences made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2304 holding.
  • Aperio Group first reported a position in Precision BioSciences in Q1 2020 and has held it in 4 quarters since.
  • 118 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.